You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 8, August 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Socioeconomics and Health Services
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Articles for Residents
 •Glaucoma
 •Drug Therapy
 •Alert me on articles by topic

Medicare Prescription Drug Cards

Effectiveness for Patients With Glaucoma

Ankit A. Mahadevia, BA; Shantanu Nundy, BS; Kevin D. Frick, PhD; Henry D. Jampel, MD, MHS

Arch Ophthalmol. 2006;124:1175-1179.

Objective  To assess the level of discounts on glaucoma medications provided by the Medicare prescription drug card program.

Methods  We compared the cost of a 1-month supply of 10 brand-name drugs and 1 commonly prescribed combination of drugs purchased at retail cash price, Medicare card–discounted price, and online price. Retail cash prices were collected through a telephone survey of 36 chain pharmacies in 4 states. Card-discounted prices were obtained from an online database updated weekly by Medicare for each drug, drug card, and state in our survey. Prices for drugs purchased online were collected from a leading online drugstore not affiliated with any retail stores that were included in the telephone survey.

Results  Card-discounted prices for each drug ranged between 13% and 25% lower on average than retail prices. However, drugs purchased online were cheaper on average than drugs purchased with cards for 7 of the 10 medications surveyed.

Conclusions  Drug cards provide significant discounts over retail prices. However, cards may be a secondary option to online purchasing, which may be cheaper and may offer seniors more flexibility to switch between glaucoma therapies. Ophthalmologists can take simple steps to guide seniors to the optimal purchasing option for a given drug in their region.


Author Affiliations: School of Medicine (Messrs Mahadevia and Nundy and Dr Jampel) and Bloomberg School of Public Health (Dr Frick), Johns Hopkins University, Baltimore, Md.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.